Compare Hims and Hers Health Inc (HIMS) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs JetBlue Airways Corporation — how do they compare? Hims and Hers Health Inc trades at $30.88 (market cap $6.55B), while JetBlue Airways Corporation trades at $3.85 (market cap $1.48B). The key difference: Hims and Hers Health Inc is far larger — about 4.4× JetBlue Airways Corporation's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and JetBlue Airways Corporation for 44 Days on average.
| HIMS | JBLU | |
|---|---|---|
Market Cap | $6.55B | $1.48B |
Volume | 14,842,814 | 30,275,693 |
Sector | Health | Industrials |
52-Week High | $62.76 | $6.46 |
52-Week Low | $14.52 | $3.92 |
Typical Hold Time | 21 Days | 44 Days |
Enterprise Value | $7.25B | $8.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $30.12, up 1.96% on the day, amid a bearish technical outlook and mixed fundamentals. The stock faces headwinds from a securities class action lawsuit related to an FTC complaint, with multiple law firms alerting investors ahead of a November 2, 2026 deadline. Financially, revenue grew to $2.35 billion in 2025, but net income turned negative in 2026, with a net loss of $142 million and a profit margin of -5.51%. Analyst consensus is a 'Hold' with a $32.17 price target, indicating limited upside from current levels.
The outlook for HIMS is cautious due to legal overhangs and profitability challenges. Investment opportunities hinge on resolving regulatory issues and returning to earnings growth, but risks include prolonged litigation, competitive pressures, and execution missteps. The stock's high valuation multiples, such as a P/E of 57.14, add vulnerability if growth disappoints.
JetBlue (JBLU) trades at $3.84, down 3.27% today, reflecting ongoing challenges in the airline sector. The stock shows bearish technical signals with negative moving averages and oscillators. Fundamentally, JBLU reported a net loss of $602 million in 2025 with negative profit margins, though revenue remains stable at $9.06 billion. Recent developments include route expansion to Colombia and the launch of BlueFirst premium seating, while activist investor Carl Icahn recently reduced board representation.
The outlook remains challenging with elevated fuel costs and competitive pressures. While the stock trades below book value (P/B 0.93) and analyst consensus target of $5.89, persistent losses and high debt levels pose significant risks. Institutional buying by Bank of America provides some support, but profitability improvement is essential for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
